MARKET

HSCS

HSCS

HeartSciences Inc
NASDAQ
2.080
-0.080
-3.70%
After Hours: 2.200 +0.12 +5.77% 19:15 04/10 EDT
OPEN
2.250
PREV CLOSE
2.160
HIGH
2.350
LOW
2.060
VOLUME
14.36K
TURNOVER
--
52 WEEK HIGH
6.47
52 WEEK LOW
2.010
MARKET CAP
6.62M
P/E (TTM)
-0.4156
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HSCS last week (0330-0403)?
Weekly Report · 5d ago
HeartSciences COO and Longtime Board Member Passes Away
TipRanks · 04/03 21:53
HEARTSCIENCES INC - DOES NOT ANTICIPATE HIRING NEW CHIEF OPERATING OFFICER - SEC FILING
Reuters · 04/03 21:17
HeartSciences COO and director Mark Hilz dies; company won’t replace role soon
Reuters · 04/03 21:15
Weekly Report: what happened at HSCS last week (0323-0327)?
Weekly Report · 03/30 09:08
HeartSciences to Present at Investor Summit Group Virtual Conference and Hold One-on-One Investor Meetings
Reuters · 03/24 15:18
Correction to HeartSciences Rating
Dow Jones · 03/24 13:44
Pfizer To Rally More Than 34%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 03/24 13:40
More
About HSCS
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.

Webull offers HeartSciences Inc stock information, including NASDAQ: HSCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSCS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HSCS stock methods without spending real money on the virtual paper trading platform.